North America CT Market

North America CT Market Size (2024 to 2029)

The CT Market size in North America was worth USD 2.74 billion in 2024 and is estimated to reach USD 3.41 billion by the end of 2029, growing at a CAGR of 4.44% between 2024 to 2029.

The North American CT Market is expected to be driven by factors such as the proliferation of chronic diseases such as cancer, the growing demand for early diagnosis, and the rising preference for minimally invasive diagnostic procedures across the region. Also, the increasing CT scans over other imaging modalities is expected to boost the market growth. In addition, the significant advancements in imaging technology promise to promote wellness by allowing faster and more accurate diagnoses of medical issues. The expanding elderly population, the increase in the prevalence of chronic diseases, and the shift in medical care toward image-guided interventions and technological improvements contribute to the North American CT Market.

On the other hand, owing to the emergence of Covid-19, the demand for home care and imaging is significantly increased. In addition, the growing use of CT scans to assess the efficacy of post-interventional medical treatments, medical implants, and anatomical confirmations is driving the market forward.

Furthermore, the growing geriatric population is significantly increasing the growth of the CT Market. The senior population is more suspected of various chronic diseases such as cancer, orthopedic, cardiovascular, and dental illnesses are becoming more prevalent, which would boost the CT Market’s growth. Also, the number of medical implant operations is expected to rise due to changing lifestyles.

However, an increase in the fiscal deficit may hinder the expansion of the CT Market in North America. Furthermore, the CT imaging radiation dose remains a source of concern. Many patients and medical organizations have raised this problem and spoken out against the potential side effects of CT scanning. As a result, the CT Market is focusing on minimizing exposure while maintaining image quality.

This research report on the North America CT Market has been segmented & sub-segmented into the following categories:

North America CT Market Analysis By Low-slice Type 

• Single Slice
• Dual Slice

North America CT Market Analysis By Slice Type 

• 6 Slice
• 10 Slice
• 16 Slice
• 32 Slice

North America CT Market Analysis By High-slice Type 

• 40 Slice
• 64 Slice
• Open Versions
• Cardiac CT

North America CT Market Analysis By End-Users 

• Hospitals and Clinics
• Imaging Centers
• Others

North America CT Market Analysis By Region 

• The United States
• Canada
• Rest of North America

Geographically, North America dominated the global CT Market in 2020, and it is anticipated to account significant share during the forecast period. The regional market growth is attributed to the availability of advanced healthcare infrastructure, increasing healthcare spending, and favorable reimbursement policies. In addition, the North American market is likely to have a leading position in the global CT Market during the projection period due to the rapid acceptance of current technology and the development of new equipment in favor of patient safety.

With new techniques, the devices allow the patient to be exposed to lower levels of stronger radiation, resulting in fewer adverse effects, boosting the market in this region. In addition, increasing per capita income in both developed and emerging countries are also encouraging market expansion. As a result, the United States, Canada, and the rest of North America are the countries that are significant contributors to the North American CT Market.

The United States dominated the largest share of the CT Market, and it is projected to register a predominant share during the forecast period. Due to the vast patient population suffering from chronic diseases, quick technical improvements, and patients’ propensity toward newer technologies, the United States significantly dominated the North American CT Market. Chronic diseases account for seven out of ten deaths in the United States, killing almost 1.7 million people yearly. Therefore, early diagnosis of chronic diseases is being researched to reduce the impact of chronic diseases on individuals and society.

According to the World Health Organization (WHO), chronic diseases such as cardiovascular diseases (CVDs), musculoskeletal disorders, cancer, and other lifestyle diseases are the significant causes of death in the United States.

On the other hand, the Canadian market is expected to showcase a promising share in the CT Market. CT scans are increasingly being utilized to diagnose these disorders, driving their demand. In addition, CT procedures are a favored choice of imaging because of the ease of access to technology and the low cost of operations compared to other modalities.

KEY MARKET PLAYERS

Companies playing a significant role in the North American CT Market profiled in this report are GE Healthcare, Hitachi Medical Corporation, Hitachi Medical Systems America, Inc., NeuroLogica Corporation, Neusoft Medical Systems Co. Ltd., Philips Healthcare, Shenzhen Anke High-Tech Co., Siemens Healthcare, and Toshiba Medical Systems Corporation.